Marksans Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Marksans Pharma	Strides Pharma Scien	Procter&Gamble Healt
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	25.0 .	230.0 .	n/a
Number of ANDA's Approved By USFDA	13.0 .	215.0 .	n/a
R&D as a % of Total Sales	2.0 %	1.84 %	n/a
Financials
5 yr Average ROE	17.57 %	23.7 %	36.03 %
5yr average Equity Multiplier	1.33	2.62	1.79
5yr Average Asset Turnover Ratio	0.9	0.6	0.77
5yr Avg Net Profit Margin	14.56 %	12.9 %	19.19 %
Price to Book	3.2	2.98	15.25
P/E	24.5	20.66	30.81
5yr Avg Cash Conversion Cycle	71.65 Days	-51.45 Days	-155.74 Days
Inventory Days	89.77 Days	69.05 Days	36.01 Days
Days Receivable	65.99 Days	60.35 Days	40.92 Days
Days Payable	88.81 Days	225.58 Days	215.28 Days
5yr Average Interest Coverage Ratio	38.03	0.72	500.05
5yr Avg ROCE	21.95 %	10.5 %	30.21 %
5yr Avg Operating Profit Margin	20.32 %	12.17 %	27.53 %
5 yr average Debt to Equity	0.02	1.01	0.0
5yr CAGR Net Profit	10.03 %	68.01 %	4.02 %
5yr Average Return on Assets	13.19 %	10.97 %	15.5 %
Shareholdings
Promoter Holding	43.87 %	27.86 %	51.82 %
Share Pledged by Promoters	0.0	44.13 %	0.0
Change in Promoter Holding (3 Yrs)	-4.73 %	-3.21 %	-0.03 %
Change in Mutual Fund Holding (3 Yrs)	2.97 %	0.16 %	3.66 %

	Marksans Pharma	Strides Pharma Scien	Procter&Gamble Healt
Product Wise Break-Up	Product Wise Break-Up Pain Management 44.0 Cough and colds 14.0 Cardiac Science 9.2 Gastro Intestinal 8.5 Central Nervous System (CNS) 8.1 Anti - Diabetes 1.6 Vitamins & Suppliments 0 Anti-Cancer 0 Anti-Hair Fall 0 Antibiotics 0 Anti-allergic 0 Miscellaneous 0 Pharmaceutical 0 Others 14.6	Product Wise Break-Up Central Nervous System (CNS) 0 Anti-allergic 0 Cough and colds 0 Vitamins & Suppliments 0 Anti-Hair Fall 0 Miscellaneous 0 Pharmaceutical 100.0 Gastro Intestinal 0 Pain Management 0 Antibiotics 0 Anti - Diabetes 0 Anti-Cancer 0 Cardiac Science 0	-
Location Wise Break-Up	Location Wise Break-Up North America 52.8 Europe 32.9 Australia 9.2 India 0 Asia (excluding India) 0 Africa 0 International 0 Domestic 0 Others 5.1	Location Wise Break-Up India 0.35 Domestic 0 Asia Pacific 0.49 Africa 10.11 International 0 Europe 21.77 Australia 9.63 North America 53.68 Others 3.97	Location Wise Break-Up India 0 Domestic 93.19 Asia (excluding India) 0 Africa 0 International 6.81 Europe 0 Australia 0 North America 0
Customer Segment	Customer Segment OTC 78.8 Rx 21.2 Institutional Business 0 Emerging Market 0 Regulated market 0	Customer Segment Institutional Business 0 OTC 0 Regulated market 83.0 Emerging Market 11.0 Rx 0 Others 6.0	-